{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T17:05:45Z","timestamp":1779555945640,"version":"3.53.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.prp.2026.156523","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:53:24Z","timestamp":1778547204000},"page":"156523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Multimodal molecular profiling of invasive ductal carcinoma: High concordance of qPCR with FISH in HER2 assessment and exomic landscape of high-risk subtypes"],"prefix":"10.1016","volume":"284","author":[{"given":"Shilpa","family":"Balar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esha","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Rawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiram","family":"Saiyad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moquitul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urja","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2026.156523_bib1","first-page":"1","article-title":"Global Cancer Statistics 2022: the trends projection analysis","volume":"10","author":"Chhikara","year":"2023","journal-title":"Chem. Biol. Lett."},{"key":"10.1016\/j.prp.2026.156523_bib2","first-page":"5748","volume":"13","author":"Huang","year":"2021","journal-title":"Global incidence mortality breast cancer a trend analysis"},{"key":"10.1016\/j.prp.2026.156523_bib3","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.bbagen.2007.01.017","article-title":"Biomarkers for early detection of breast cancer: what, when, and where?","volume":"1770","author":"Levenson","year":"2007","journal-title":"Biochim. Biophys. Acta - Gen. Subj."},{"key":"10.1016\/j.prp.2026.156523_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/jclinpath-2014-202571","article-title":"Updated UK recommendations for HER2 assessment in breast cancer","volume":"68","author":"Rakha","year":"2015","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.prp.2026.156523_bib5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.breast.2020.09.006","article-title":"Clinicopathological characteristics and prognosis of breast cancer with special histological types: a surveillance, epidemiology, and end results database analysis","volume":"54","author":"Han","year":"2020","journal-title":"Breast"},{"key":"10.1016\/j.prp.2026.156523_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00428-014-1593-7","article-title":"Molecular classification of breast cancer","volume":"465","author":"Vuong","year":"2014","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2026.156523_bib7","first-page":"773","article-title":"Immunohistochemical analysis of ER, PR, Her2 and CK5\/6 in infiltrative breast carcinomas in indian patients","volume":"10","author":"Munjal","year":"2009","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.prp.2026.156523_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2021.07.010","article-title":"Breast cancer heterogeneity through the lens of single-cell analysis and spatial pathologies","volume":"82","author":"Zhao","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.prp.2026.156523_bib9","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1503\/cmaj.061011","article-title":"Testing for HER2-positive breast cancer: a systematic review and cost-effectiveness analysis","volume":"176","author":"Dendukuri","year":"2007","journal-title":"C. Can. Med. Assoc. J."},{"key":"10.1016\/j.prp.2026.156523_bib10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10549-020-05772-6","article-title":"Differential prognostic value of positive HER2 status determined by immunohistochemistry or fluorescence in situ hybridization in breast cancer","volume":"183","author":"Stocker","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2026.156523_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/PAI.0000000000000849","article-title":"Cost-effectiveness of a dual (immunohistochemistry and fluorescence in situ hybridization) HER2\/neu testing strategy on invasive breast cancers","volume":"29","author":"Hariri","year":"2021","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.prp.2026.156523_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10549-019-05148-5","article-title":"Impact of the updated 2018 ASCO\/CAP guidelines on HER2 FISH testing in invasive breast cancer: a retrospective study of HER2 fish results of 2233 cases","volume":"175","author":"Liu","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2026.156523_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5858\/arpa.2013-0953-SA","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology\/college of American pathologists clinical practice guideline update","volume":"138","author":"Wolff","year":"2014","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.prp.2026.156523_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcancer.2020.02.016","article-title":"Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond","volume":"72","author":"Marchi\u00f2","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.prp.2026.156523_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-017-1195-7","article-title":"Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases","volume":"15","author":"Zoppoli","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.prp.2026.156523_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.36877\/pmmb.a0000332","article-title":"A Study Comparing Immunohistochemistry, Fluorescence in situ Hybridization, and GeneXpert\u00ae Breast Cancer STRAT4 assay for Determining Hormone Receptor, Human Epidermal Growth Factor Receptor 2, and Ki67 Status in Invasive Breast Carcinoma in Moroccan Wome","volume":"6","author":"El Aje","year":"2023","journal-title":"Prog. Microbes Mol. Biol."},{"key":"10.1016\/j.prp.2026.156523_bib17","first-page":"1173","article-title":"BRAC1 and BRAC2 mutation and treatment strategies for breast cancer","volume":"344","author":"Yang","year":"2015","journal-title":"HHS Pulic Access"},{"key":"10.1016\/j.prp.2026.156523_bib18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/his.14794","article-title":"Next-generation sequencing in breast pathology: real impact on routine practice over a decade since its introduction","volume":"82","author":"Nourieh","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2026.156523_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12071832","article-title":"Molecular features of metaplastic breast carcinoma: an infrequent subtype of triple negative breast carcinoma","volume":"12","author":"Gonz\u00e1lez-Mart\u00ednez","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2026.156523_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12092490","article-title":"Single-cell NGS-based analysis of copy number alterations reveals new insights in circulating tumor cells persistence in early-stage breast cancer","volume":"12","author":"Rossi","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2026.156523_bib21","first-page":"1","article-title":"Impact of the 2018 ASCO\/CAP guidelines on HER2 fluorescence in situ hybridization interpretation in invasive breast cancers with immunohistochemically equivocal results","volume":"9","author":"Wang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2026.156523_bib22","first-page":"217","article-title":"Comparison of Immunohistochemical Methods (IHC) and Fluorescent in Situ Hybridization (FISH) in the Detection of HER 2\/Neu Gene in Kurdish Patients with Breast Cancer in Western Iran","volume":"16","author":"Aznab","year":"2022","journal-title":"Int. J. Hematol. Stem Cell Res."},{"key":"10.1016\/j.prp.2026.156523_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1055\/s-0042-1751052","article-title":"Indian Data on HER2 Fluorescence in Situ Hybridization in Invasive Breast Cancer with Immunohistochemically Equivocal Results As per 2018 ASCO\/CAP Guidelines","volume":"11","author":"Nagarjun","year":"2022","journal-title":"South Asian J. Cancer"},{"key":"10.1016\/j.prp.2026.156523_bib24","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.5858\/arpa.2018-0902-SA","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Focused Update","volume":"142","author":"Wolff","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.prp.2026.156523_bib25","unstructured":"S. Adrews, FastQC: A quality control tool for high throughput sequence data, \u3008Https:\/\/Www.Bioinformatics.Babraham.Ac.Uk\/Projects\/Fastqc\/\u3009 (2010)."},{"key":"10.1016\/j.prp.2026.156523_bib26","series-title":"A wrapper tool around Cutadapt and FastQC to consistently apply quality and adapter trimming to FastQ files","author":"Krueger F","year":"2012"},{"key":"10.1016\/j.prp.2026.156523_bib27","unstructured":"Franklin, (n.d.). \u3008https:\/\/franklin.genoox.com\/clinical-db\/home\u3009 (accessed March 3, 2026)."},{"key":"10.1016\/j.prp.2026.156523_bib28","doi-asserted-by":"crossref","first-page":"D733","DOI":"10.1093\/nar\/gkv1189","article-title":"Reference sequence (RefSeq) database at NCBI: Current status, taxonomic expansion, and functional annotation","volume":"44","author":"O\u2019Leary","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.prp.2026.156523_bib29","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: Improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.prp.2026.156523_bib30","doi-asserted-by":"crossref","first-page":"D789","DOI":"10.1093\/nar\/gku1205","article-title":"OMIM.org: Online Mendelian Inheritance in Man (OMIM\u00ae), an Online catalog of human genes and genetic disorders","volume":"43","author":"Amberger","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.prp.2026.156523_bib31","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: The Catalogue Of Somatic Mutations In Cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.prp.2026.156523_bib32","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","article-title":"K. Sirotkin, DbSNP: The NCBI database of genetic variation","volume":"29","author":"Sherry","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.prp.2026.156523_bib33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.prp.2026.156523_bib34","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.prp.2026.156523_bib35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.prp.2026.156523_bib36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nmeth.2890","article-title":"Mutationtaster2: mutation prediction for the deep-sequencing age","volume":"11","author":"Schwarz","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.prp.2026.156523_bib37","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.prp.2026.156523_bib38","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2009.86","article-title":"Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm","volume":"4","author":"Kumar","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.prp.2026.156523_bib39","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med"},{"key":"10.1016\/j.prp.2026.156523_bib40","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10549-018-5067-5","article-title":"Genomic profile of breast sarcomas: a comparison with malignant phyllodes tumours","volume":"174","author":"Lim","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2026.156523_bib41","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.prp.2026.156523_bib42","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.prp.2026.156523_bib43","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/cas.14313","article-title":"Using next-generation sequencing to redefine BRCAness in triple-negative breast cancer","volume":"111","author":"Lin","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.prp.2026.156523_bib44","doi-asserted-by":"crossref","first-page":"8145","DOI":"10.2147\/CMAR.S208323","article-title":"Recent insights into breast cancer incidence trends among four Asian countries using age-period-cohort model","volume":"11","author":"Mubarik","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.prp.2026.156523_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers15061917","article-title":"What Is Known about Breast Cancer in Young Women?","volume":"15","author":"Zhu","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2026.156523_bib46","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4103\/2278-0513.142652","article-title":"Age shift: breast cancer is occurring in younger age groups - Is it true?","volume":"3","author":"Chopra","year":"2014","journal-title":"Clin. Cancer Investig. J."},{"key":"10.1016\/j.prp.2026.156523_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41523-019-0122-x","article-title":"Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO\/CAP ISH group 4 breast cancer","volume":"5","author":"Gupta","year":"2019","journal-title":"Npj Breast Cancer"},{"key":"10.1016\/j.prp.2026.156523_bib48","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.breast.2021.07.019","article-title":"Dissecting the biological heterogeneity of HER2-positive breast cancer","volume":"59","author":"Schettini","year":"2021","journal-title":"Breast"},{"key":"10.1016\/j.prp.2026.156523_bib49","article-title":"Targeted therapeutic options and future perspectives for her2-positive breast cancer","volume":"4","author":"Wang","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.prp.2026.156523_bib50","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/PAI.0000000000001111","article-title":"Effect of Surface Decalcification With Hydrochloric Acid on the Determination of Estrogen Receptor, Progesterone Receptor, Ki67, and Human Epidermal Growth Factor Receptor 2 Expressions in Invasive Breast Carcinoma Based on Immunohistochemistry and Fluore","volume":"31","author":"Ping","year":"2023","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.prp.2026.156523_bib51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10549-019-05295-9","article-title":"Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapy","volume":"177","author":"Krystel-Whittemore","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2026.156523_bib52","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/jcp.2007.050336","article-title":"The effect of chromosome 17 polysomy on HER-2\/neu status in breast cancer","volume":"61","author":"Hyun","year":"2008","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.prp.2026.156523_bib53","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/s41379-020-0504-5","article-title":"Integrated genomic characterization of ERBB2\/HER2 alterations in invasive breast carcinoma: a focus on unusual FISH groups","volume":"33","author":"Yang","year":"2020","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2026.156523_bib54","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.37867\/TE1401126","article-title":"Multimodality Testing of Her2\/Neu Marker in Breast Cancer: a Correlative Study","volume":"14","author":"Balar","year":"2022","journal-title":"Towar. Excell"},{"key":"10.1016\/j.prp.2026.156523_bib55","first-page":"689","article-title":"Next-generation antibody\u2013drug conjugates revolutionize the precise classification and treatment of HER2-expressing breast cancer","volume":"20","author":"Dai","year":"2023","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.prp.2026.156523_bib56","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1200\/JCO.2010.31.2835","article-title":"Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the genomic health recurrence score in early breast cancer","volume":"29","author":"Cuzick","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2026.156523_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-020-00208-2","article-title":"Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer","volume":"7","author":"Schettini","year":"2021","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.prp.2026.156523_bib58","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/modpathol.2016.39","article-title":"Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology","volume":"29","author":"Weisman","year":"2016","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2026.156523_bib59","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10549-020-05778-0","article-title":"Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy","volume":"183","author":"Li","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2026.156523_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11040604","article-title":"Gata3 as an adjunct prognostic factor in breast cancer patients with less aggressive disease: a study with a review of the literature","volume":"11","author":"Querzoli","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.prp.2026.156523_bib61","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4048\/jbc.2022.25.e41","article-title":"Somatic Mutations of TP53 Identified by Targeted Next-Generation Sequencing Are Poor Prognostic Factors for Primary Operable Breast Cancer: A Single-Center Study","volume":"25","author":"Park","year":"2022","journal-title":"J. Breast Cancer"},{"key":"10.1016\/j.prp.2026.156523_bib62","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3727\/096504019X15698362825407","article-title":"Pathway Mutations in Breast Cancer Using Whole-Exome Sequencing","volume":"28","author":"Chang","year":"2020","journal-title":"Oncol. Res."},{"key":"10.1016\/j.prp.2026.156523_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-98547-y","article-title":"Pathogenic genetic variants from highly connected cancer susceptibility genes confer the loss of structural stability","volume":"11","author":"Reza","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2026.156523_bib64","author":"Walsh","year":"2016","journal-title":"Genom. Biomark. Breast Cancer risk"},{"key":"10.1016\/j.prp.2026.156523_bib65","first-page":"1","article-title":"Alterations in Immune-Related Genes as Potential Marker of Prognosis in Breast Cancer","volume":"10","author":"Li","year":"2020","journal-title":"Front. Oncol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T16:47:32Z","timestamp":1779554852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826001767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":65,"alternative-id":["S0344033826001767"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156523","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodal molecular profiling of invasive ductal carcinoma: High concordance of qPCR with FISH in HER2 assessment and exomic landscape of high-risk subtypes","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156523","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156523"}}